Source: Eur Respir J 2010; 36: 1460-1481
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Schutz C., Meintjes G., Almajid F., Wilkinson R.J., Pozniak A.. Clinical management of tuberculosis and HIV-1 co-infection. Eur Respir J 2010; 36: 1460-1481

Member's Comments

No comment yet.

Related content which might interest you: Treatment of latent infection with Mycobacterium tuberculosis: update 2010 Source: Eur Respir J 2011; 37: 690-711 Year: 2011 Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Monitoring latent tuberculosis infection diagnosis and management in the Netherlands Source: Eur Respir J 2016; 47:1492-1501 Year: 2016 Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection Source: Eur Respir J 2010; 36: 1242-1247 Year: 2010 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces Year: 2016 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Source: Eur Respir J 2015; 46: 1563-1576 Year: 2015 Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction Source: Eur Respir Rev 2009; 18: 295-299 Year: 2009 Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection. Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Combined phenotypical and functional analysis of M. tuberculosis specific immunity for diagnosing active infection and risk assessment in latently infected individuals Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 Mycobacterium tuberculosis bacteremia in reactivation tuberculosis patients without human immunodeficiency virus infection Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005 The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine. Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018 Diagnosis and treatment of latent tuberculosis infection Source: Eur Respir Monogr 2018; 82: 381-398 Year: 2018 Microbiology of Mycobacterium tuberculosis and a new diagnostic test for TB Source: Eur Respir Mon 2012; 58: 1-13 Year: 2012 Diagnosis of latent tuberculosis infection Source: ERS Live 2007 Year: 2007 Prevalence of HIV infection among tuberculosis cases and pattern of tuberculosis and treatment outcome in HIV seropositives – a study from a tuberculosis center from India Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Pulmonary tuberculosis Source: Respipedia Article Year: 2018 Annual risk of infection with Mycobacterium tuberculosis Source: Eur Respir J 2005; 25: 181-185 Year: 2005 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014